Claris Biotherapeutics
About:
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.
Website: https://clarisbio.com/
Top Investors: RA Capital Management, Novo Holdings, Janus Henderson Investors, Mass General Brigham Ventures
Description:
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
Total Funding Amount:
$101M
Headquarters Location:
Jersey City, New Jersey, United States
Founded Date:
2018-01-01
Founders:
Reza Dana, Sunil Chauhan
Number of Employees:
1-10
Last Funding Date:
2024-01-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai